Patents by Inventor Cornelis T Verrips

Cornelis T Verrips has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9080157
    Abstract: The use of VHHs in the preparation of products to provide stability of antibody specificity under destabilizing conditions whereby normally lower eukaryotes or traditional antibodies are killed or inactivated.
    Type: Grant
    Filed: May 2, 2012
    Date of Patent: July 14, 2015
    Assignee: BAC IP B.V.
    Inventors: Daniel Convents, Leo G. Frenken, Michael M. Harmsen, Richard H. van der Linden, Cornelis T. Verrips
  • Patent number: 8951755
    Abstract: The use of VHHs in the preparation of products to provide stability of antibody specificity under destabilizing conditions whereby normally lower eukaryotes or traditional antibodies are killed or inactivated.
    Type: Grant
    Filed: March 12, 1999
    Date of Patent: February 10, 2015
    Assignee: BAC IP B.V.
    Inventors: Daniel Convents, Leo G. Frenken, Michael M. Harmsen, Richard H. van der Linden, Cornelis T. Verrips
  • Publication number: 20120309054
    Abstract: The use of VHHs in the preparation of products to provide stability of antibody specificity under destabilising conditions whereby normally lower eukaryotes or traditional antibodies are killed or inactivated.
    Type: Application
    Filed: May 2, 2012
    Publication date: December 6, 2012
    Inventors: Daniel Convents, Leo G. Frenken, Michael M. Harmsen, Richard M. van der Linden, Cornelis T. Verrips
  • Patent number: 7794981
    Abstract: A process is provided for the production of an antibody or a fragment or functionalized fragment thereof using a transformed lower eukaryotic host containing an example DNA sequence encoding the antibody or (functionalized) fragment thereof, wherein the antibody or (functionalized) fragment thereof is derived from a heavy chain immunoglobulin of Camelidae and is devoid of light chains, and wherein the lower eukaryotic host is a mould, preferably belonging to the genera Aspergillus or Trichoderma, or a yeast, preferably belonging to the yeast genera Saccharomyces, Kluyveromyces, Hansenula, or Pichia. The heavy chain fragment can contain at least the whole variable domain. A complementary determining region (CDR) different from the CDR belonging to the natural antibody ex Camelidae can be grafted on the framework of the variable domain of the heavy chain immunoglobulin. The catalytic antibodies can be raised in Camelidae against transition state molecules.
    Type: Grant
    Filed: August 11, 2004
    Date of Patent: September 14, 2010
    Assignee: BAC IP B.V.
    Inventors: Raymond Hamers, Cecile Hamers-Casterman, Serge V. M. Muyldermans, Leon G. J. Frenken, Cornelis T Verrips
  • Patent number: 6838254
    Abstract: A process is provided for the production of an antibody or a fragment or functionalized fragment thereof using a transformed lower eukaryotic host containing an expressible DNA sequence encoding the antibody or (functionalized) fragment thereof, wherein the antibody or (functionalized) fragment thereof is derived from a heavy chain immunoglobulin of Camelidae and is devoid of light chains, and wherein the lower eukaryotic host is a mould, preferably belonging to the genera Aspergillus or Trichoderma, or a yeast, preferably belonging to the yeast genera Saccharomyces, Kluyveromyces, Hansenula, or Pichia. The heavy chain fragment can contain at least the whole variable domain. A complementary determining region (CDR) different from the CDR belonging to the natural antibody ex Camelidae can be grafted on the framework of the variable domain of the heavy chain immunoglobulin. The catalytic antibodies can be raised in Camelidae against transition state molecules.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: January 4, 2005
    Assignee: Conopco, Inc.
    Inventors: Raymond Hamers, Cecile Hamers-Casterman, Serge V.M Muyldermans, Leon G. J Frenken, Cornelis T Verrips
  • Patent number: 6090574
    Abstract: A process is disclosed for preparing a protein by a eukaryote transformed by multicopy integration of an expression vector into the genome of a yeast, such as Saccharomyces, Hansenula, and Kluyveromyces, or of a mould such as Aspergillus, Rbizopus and Trichoderma, the expression vector containing both an "expressible gene" encoding the protein and a so-called "deficient selection marker meeded for the growth of the yeast or mould in a specific medium", such as the LEU2d, TRP1d or URA3d gene, in combination witha ribosomal DNA sequence, resulting in stable high copy integration of 100-300 copies per cell. This multicopy integration results in an increased production of the desired protein, which can be guar .alpha.-galactosidase, an oxidase or a hydrolytic enzyme such as a lipase.
    Type: Grant
    Filed: December 27, 1994
    Date of Patent: July 18, 2000
    Assignee: Unilever Patent Holdings, B.V.
    Inventors: Marco F. Giuseppin, Maria T. S. Lopes, Roelf J. Planta, Johannes M. A. Verbakel, Cornelis T. Verrips
  • Patent number: 6027910
    Abstract: A method is provided for immobilizing an enzyme, comprising immobilizing the enzyme or a functional part thereof to the cell wall of a microbial cell using recombinant DNA techniques. The enzyme is immobilized by linking it to the C-terminal part of a protein that ensures anchoring in the cell wall. Also provided is a recombinant polynucleotide comprising a structural gene encoding an enzyme protein, a part of a gene encoding the C-terminal part of a protein capable of anchoring in a eukaryotic or prokaryotic cell wall, as well as a signal sequence, in addition to a chimeric protein encoded by the recombinant polynucleotide and a vector and a microorganism containing the polynucleotide. The microorganism is suitable for carrying out enzymatic processes on an industrial scale.
    Type: Grant
    Filed: February 27, 1995
    Date of Patent: February 22, 2000
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Franciscus M Klis, Maarten P Schreuder, Holger Y Toschka, Cornelis T Verrips
  • Patent number: 6004776
    Abstract: A process is disclosed for preparing a protein by a eukaryote transformed by multicopy integration of an expression vector into the genome of a yeast, such as Saccharomyces, Hansenula, and Kluyveromyces, or of a mould such as Aspergillus, Rhizopus and Trichoderma, the expression vector containing both an "expressible gene" encoding the protein and a so-called "deficient selection marker needed for the growth of the yeast or mould in a specific medium", such as the LEU2d, TRP1d or URA3d gene, in combination with a ribosomal DNA sequence, resulting in stable high copy integration of 100-300 copies per cell. This multicopy integration results in an increased production of the desired protein, which can be guar .alpha.-galactosidase, an oxidase or a hydrolytic enzyme such as a lipase.
    Type: Grant
    Filed: November 15, 1996
    Date of Patent: December 21, 1999
    Assignee: Unilever Patent Holdings, B.V.
    Inventors: Marco F. Giuseppin, Maria T. S. Lopes, Roelf J. Planta, Johannes M. A. Verbakel, Cornelis T. Verrips
  • Patent number: 5741672
    Abstract: The structural genes and their regulatory DNA sequences of an alcohol oxidase (MOX) and a dihydroxyacetone synthase (DHAS) of Hansenula polymorpha have been isolated and the nucleotide sequences determined. The invention relates to the use of the MOX gene, as well as the use of the regulatory DNA sequences of MOX and/or DAS in combination with the MOX gene, optionally after modification thereof, or other oxidase genes, or other genes, to produce engineered microorganisms, 0in particular yeasts. Said engineered microorganisms can produce oxidases or other enzymes in yields that allow industrial application on a large scale. Moreover, said engineered microorganisms can produce oxidases having improved properties with respect to their application in oxidation reactions and/or in bleaching and detergent products.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: April 21, 1998
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Adrianus M. Ledeboer, Jan Maat, Cornelis T. Verrips, Christiaan Visser, Zbigniew A. Janowicz, Cornelis P. Hollenberg
  • Patent number: 5627072
    Abstract: A food-grade vector is provided which is suitable for transforming a food-grade host cell and is incapable of replicating autonomously in the host cell due to deletion of the replicase gene.
    Type: Grant
    Filed: January 3, 1995
    Date of Patent: May 6, 1997
    Assignee: Van Den Bergh Foods Co., Division of Conopco Inc.
    Inventors: Cornelis J. Leenhouts, John D. Marugg, Cornelis T. Verrips
  • Patent number: 5601750
    Abstract: An enzymatic bleach composition is provided comprising an enzymatic hydrogen peroxide-generating system and a bleach catalyst which is a coordination complex comprising manganese (Mn) and/or iron (Fe) ions, and preferably comprising a ligand L which is a macrocyclic organic compound of formula (I): ##STR1## wherein t is an integer form 2 to 3; s is an integer from 3 to 4, u is zero or one; each R.sup.1, R.sup.2 and R.sup.3 are independently selected from H, alkyl, aryl, substituted alkyl, and substituted aryl.
    Type: Grant
    Filed: September 7, 1994
    Date of Patent: February 11, 1997
    Assignee: Lever Brothers Company, Division of Conopco, Inc.
    Inventors: Todd Domke, Charles C. Nunn, Marco L. Giuseppin, Rudolf J. Martens, Ton Swarthoff, Cornelis T. Verrips
  • Patent number: 5420021
    Abstract: The invention relates to a process for the production of .alpha.-acetolactate and/or diacetyl, wherein a recombinant micro-organism containing an .alpha.-acetolactate synthase-encoding sequence is incubated in a medium containing an .alpha.-acetolactate precursor. The invention also provides a recombinant vector comprising a nucleotide sequence coding for an enzyme, which vector upon transfer into a host micro-organism enables expression of the nucleotide sequence in the host micro-organism, wherein the enzyme has .alpha.-acetolactate synthase activity.
    Type: Grant
    Filed: February 24, 1992
    Date of Patent: May 30, 1995
    Assignee: Unilever Patent Holdings B.V.
    Inventors: John D. Marugg, Maria Y. Toonen, Walter M. M. Verhue, Cornelis T. Verrips
  • Patent number: 5240838
    Abstract: The structural genes and their regulatory DNA sequences of an alcohol oxidase (MOX) and a dihydroxyacetone synthase (DHAS) of Hansenula polymorpha have been isolated and the nucleotide sequences determined. The invention relates to the use of the MOX gene, as well as the use of the regulatory DNA sequences of MOX and/or DAS in combination with the MOX gene, optionally after modification thereof, or other oxidase genes, or other genes, to produce engineered microorganisms, in particular yeasts. Said engineered microorganisms can produce oxidases or other enzymes in yields that allow industrial application on a large scale. Moreover, said engineered microorganisms can produce oxidases having improved properties with respect to their application in oxidation reactions and/or in bleaching and detergent products.
    Type: Grant
    Filed: September 24, 1990
    Date of Patent: August 31, 1993
    Assignee: Internationale Otrool Maatschappij "Octropa" B.V.
    Inventors: Adrianus M. Ledeboer, Jan Maat, Cornelis T. Verrips, Christiaan Visser, Zbigniew A. Janowicz, Cornelis P. Hollenberg
  • Patent number: 4966842
    Abstract: The invention relates to structural genes consisting of DNA sequences encoding non-processed and partly processed thaumatin, to the various allelic forms of said non-processed thaumatin and to recombinant DNA's and plasmids comprising said structural genes coding for the various allelic forms of preprothaumatin, and naturally and/or artificially modified preprothaumatin in various stages of its natural processing, and to the use of said recombinant plasmids to transform microorganisms, particularly bacteria in which said genes are expressed.
    Type: Grant
    Filed: May 17, 1988
    Date of Patent: October 30, 1990
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Cornelis T. Verrips, Jan Maat, Luppo Edens, Adrianus M. Ledeboer
  • Patent number: 4891316
    Abstract: The invention relates to DNA sequences encoding the various allelic forms of mature thaumatin, and cloning vehicles comprising said DNA sequences and their use in transforming microorganisms.
    Type: Grant
    Filed: June 7, 1985
    Date of Patent: January 2, 1990
    Assignee: Unilever Patent Holdings B.V.
    Inventors: Cornelis T. Verrips, Adrianus M. Ledeboer, Luppo Edens, Robert Klok, Jan Maat
  • Patent number: 4771000
    Abstract: The invention relates to structural genes comprising encoding non-processed and partly processed thaumatin, to the various allelic forms of said non-processed thaumatin and to recombinant DNA's and plasmids comprising said structural genes coding for the various allelic forms of preprothaumatin, and naturally and/or artifically modified preprothaumatin in various stages of its natural processing, and to the use of said recombinant plasmids to transform microorganisms, particularly bacteria in which said genes are expressed.
    Type: Grant
    Filed: May 10, 1985
    Date of Patent: September 13, 1988
    Assignee: Internationale Octrooi Maatschappij Octropa B.V.
    Inventors: Cornelis T. Verrips, Jan Maat, Luppo Edens, Adrianus M. Ledeboer
  • Patent number: 4336272
    Abstract: Oil-in-water emulsions, which are microbiologically stable upon storage, consisting of oil, water, thickeners, emulsifiers, and optional further ingredients, are obtained by subjecting at least one of these components to an osmotic and/or acid shock and to a temperature shock by heating said component(s) within 3 minutes, preferably within 1 minute, to 40.degree.-55.degree. C., preferably to 45.degree.-50.degree. C., and processing the thus treated component(s) with the remaining ingredients into a final emulsion, during which the temperature of the final emulsion up to and including the filling and hermetically sealing of the containers into which it is being packed, is maintained at 40.degree.-55.degree. C. Preferably the temperature shock is achieved by adding during the preparation of the final emulsion a thickener suspension having a temperature of 70.degree.-95.degree. C. to the remaining components which have been subjected to an osmotic and/or acid shock.
    Type: Grant
    Filed: October 17, 1980
    Date of Patent: June 22, 1982
    Assignee: Lever Brothers Company
    Inventors: Cornelis T. Verrips, Renee van Rhee